NR565 Week 1 Study Guide (w/ Quiz 1)

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/36

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

37 Terms

1
New cards

Question

Answer

2
New cards

What determines an NP’s prescriptive authority?

State law and licensure level (NP, PA, MD) determine authority. Some states require collaborative agreements, and controlled substance prescribing requires DEA registration.

3
New cards

In a restricted-practice state, what must an NP do to prescribe?

They must have formal physician oversight for certain aspects of care.

4
New cards

What must every prescription legally include?

Prescriber details (name, NPI, DEA if controlled), patient info, drug name/strength/form, directions, quantity, refills, and signature.

5
New cards

What is the primary legal risk of off-label prescribing?

Patients may file complaints or lawsuits if adverse effects occur, since use is outside FDA-approved labeling.

6
New cards

What are the four pharmacokinetic processes?

Absorption, Distribution, Metabolism, and Excretion (ADME).

7
New cards

What determines how much drug reaches systemic circulation?

Absorption —> influenced by route, pH, motility, food, and bioavailability.

8
New cards

Why do oral drugs often have reduced bioavailability?

Because of first-pass hepatic metabolism before reaching systemic circulation.

9
New cards

How does urine pH affect drug excretion?

Acidic urine enhances excretion of weak bases; alkaline urine enhances excretion of weak acids (e.g., sodium bicarb for aspirin overdose).

10
New cards

What is protein binding, and why is it important?

Only unbound drug is active. High protein binding (e.g., warfarin) prolongs action but increases interaction risk. Low albumin increases toxicity risk.

11
New cards

Compare lipid- vs. water-soluble drugs in distribution.

Lipid-soluble drugs cross membranes easily, have wider distribution, and longer half-lives; water-soluble drugs stay in plasma and clear faster.

12
New cards

What does a high volume of distribution (Vd) indicate?

A drug distributes widely into tissues (lipophilic, long-acting).

13
New cards

Where does most drug metabolism occur?

In the liver via CYP450 enzymes; also in intestines, lungs, and kidneys.

14
New cards

Describe Phase I vs Phase II metabolism.

Phase I: oxidation, reduction, or hydrolysis (adds/reveals polar group). Phase II: conjugation (adds molecule like glucuronide for excretion).

15
New cards

What’s the clinical impact of CYP450 induction and inhibition?

Inducers (e.g., rifampin, St. Johnâ€s Wort) decrease drug levels; inhibitors (e.g., ketoconazole, grapefruit juice) increase levels and toxicity risk.

16
New cards

Why does genetic variation in CYP2D6 matter?

It controls codeine —> morphine conversion: poor metabolizers get no relief; ultra-rapid metabolizers risk toxicity.

17
New cards

Which renal process filters only unbound drug?

Glomerular filtration.

18
New cards

Why must CrCl or eGFR be checked before dosing renally-cleared drugs?

Decreased clearance prolongs half-life and increases toxicity risk (e.g., lithium, digoxin).

19
New cards

How do agonists and antagonists differ?

Agonists activate receptors (increase effect); antagonists block them (decrease effect).

20
New cards

Give an example of a synergistic drug interaction.

Benzodiazepines + opioids —> severe CNS depression.

21
New cards

What’s the main difference between additive and synergistic effects?

Additive = sum of effects (1+1=2); synergistic = greater than sum (1+1>2).

22
New cards

What determines a drug’s half-life?

Combined rates of metabolism and excretion.

23
New cards

How long does it take to reach steady state?

Usually 4-5 half-lives with consistent dosing.

24
New cards

What are the top strategies to minimize ADRs?

Use the lowest effective dose, monitor labs, review for interactions, avoid polypharmacy, and educate patients.

25
New cards

What do boxed warnings signify?

FDA alerts for life-threatening/disabling risks (e.g., SSRIs increase suicidality) requiring extra vigilance.

26
New cards

When is the fetus most at risk for teratogenicity?

During organogenesis (weeks 3-8 of first trimester).

27
New cards

Give two examples of teratogens and their fetal effects.

ACE inhibitors —> renal/skull defects; valproic acid —> neural tube defects.

28
New cards

What are key pharmacokinetic changes in pregnancy?

Increase blood volume & GFR (faster excretion), Decrease albumin (increases free drug), increases hepatic metabolism.

29
New cards

Why should pediatric dosing always be weight-based?

Children —> organ systems are immature; mg/kg dosing ensures safety and accuracy.

30
New cards

How does aging affect pharmacokinetics?

↓ GFR & liver enzymes → slower clearance, longer half-life, ↑ toxicity risk.

31
New cards

Why is diphenhydramine inappropriate for older adults?

Strong anticholinergic effects → confusion, delirium, falls, urinary retention.

32
New cards

What absorption differences exist in infants?

Higher gastric pH and irregular peristalsis cause delayed and unpredictable absorption.

33
New cards

Name common hepatotoxic drug classes.

Acetaminophen, valproic acid, isoniazid/rifampin, statins, and systemic azoles like ketoconazole.

34
New cards

What labs monitor for hepatotoxicity?

AST, ALT, ALP, and bilirubin.

35
New cards

How does pharmacogenomics improve prescribing?

It helps predict metabolism speed and adverse reaction risk based on genetic polymorphisms.

36
New cards

Which CYP enzymes show notable ancestry-related variability?

CYP2D6 and CYP2C19 — they influence metabolism of codeine, SSRIs, and clopidogrel.

37
New cards